节点文献

国际药品定价理论与实践对我国药品定价的启示

International Pharmaceutical Pricing Practice and Its Revelation for Pharmaceutical Pricing in China

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 吴晶李剑青黄泰康

【Author】 WU Jing, LI Jianqing, HUANG Taikang(The College of Business Administration, Shenyang Pharmaceutical University, Shenyang, 110016, China)

【机构】 沈阳药科大学现代社会药学研究中心沈阳药科大学现代社会药学研究中心 沈阳市110016沈阳市110016

【摘要】 目的:为我国制定药品价格提供借鉴。方法:分析国际药品价格制定的基本思路和做法,剖析价格制定过程中的难点,探讨国家间价格影响的途径和程度。结果与结论:从市场角度和成本角度设定的价格上线和下线决定了价格的可行范围,将新药额外价值定量化是新药价格制定的关键。我国应该对创新药品和仿制药品分别管理,对创新药品要求提供药物经济学评价来定量化额外价值,对仿制药品实行参考价格体系。

【Abstract】 OBJECTIVE: To study international pharmaceutical pricing theory and practice for improved pharmaceutical pricing in China. METHODS: The rationale and practice of international pharmaceutical pricing were analyzed, the difficulties in setting prices were discussed, and the inter-nation influence on prices was investigated. RESULTS&CONCLUSION: International practice shows that price ceiling from the market perspective and price floor from the cost perspective construct the possible price range; quantifying the extra value is the critical part of new drug pricing. It is suggested that China set innovative drugs and me-too drugs under separate control, requiring innovative drugs to provide pharmacoeconomic evaluation to quantify their extra value while implementing price reference system for me-too drugs.

【关键词】 药品价格制定价值
【Key words】 PharmaceuticalsPricingSetValue
  • 【分类号】F203
  • 【被引频次】19
  • 【下载频次】957
节点文献中: 

本文链接的文献网络图示:

本文的引文网络